Regeneron reported total revenues of $1.663 billion in the third quarter of 2018, an increase of 11% from 2017’s third quarter revenues of $1.501 billion, according to a press release.
Quarterly net income was $595 million, or $5.50 per basic share, compared with $388 million, or $3.64 per basic share, in 2017.
Research and development costs increased from $530 million to $557 million for the quarter. Selling, general and administrative expenses grew from $307 million in 2017’s third quarter to $369 million this year.
Uncategorized